AstraZeneca shares on 'positive trajectory', says Panmure Gordon
24th Apr 2014 11:22
Panmure Gordon has kept a 'hold' recommendation for AstraZeneca after a mixed first quarter from the pharmaceutical group, but said there were some 'bright lights' in the results such as its heartburn treatment Nexium. AstraZeneca said that revenue totalled $6.42bn in the three months to March 31st
Read moreLondon open: FTSE 100 rises after results from Apple, Facebook
24th Apr 2014 08:31
- Apple, Facebook lift sentiment after results - FTSE 100 at highest since March 7th - Miners Anglo, ABG and Centamin rise techMARK 2,762.55 +0.74% FTSE 100 6,708.61 +0.51% FTSE 250 16,070.47 +0.51% Forecast-beating quarterly results from Wall Street heavyweights Apple and Facebook fed through to
Read moreThursday newspaper round-up: Ukraine, AstraZeneca, Scotland
24th Apr 2014 07:05
The rhetoric between Kiev and Moscow has taken a distinct turn for the worse. On Wednesday, Russia warned that any attack on its citizens in Ukraine would be considered as an attack on itself. That came as an 'anti-terrorist' operation against pro-Russian militants in the eastern part of the country
Read moreAstraZeneca beats revenue forecasts in Q1, but earnings slide
24th Apr 2014 07:04
- Revenues up three per cent, ahead of forecasts - BMS diabetes buyout boosts top line - Earnings fall more than expected Revenues at AstraZeneca were given a boost in the first quarter by the pharmaceutical company's diabetes franchise, but earnings fell by more than expected. AstraZeneca, whose
Read moreThursday preview: Investors waiting on AstraZeneca and Barclays
23rd Apr 2014 18:52
Thursday will be another big day in capital markets in London. In particular, traders will be braced for the latest first quarter earnings figures out from drugs giant AstraZeneca. Analysts at Credit Suisse are forecasting core (based on their own definition) earnings per share (EPS) of $1.22 for t
Read moreLondon close: FTSE ends slightly lower ahead of US earnings
23rd Apr 2014 16:59
- FTSE closes down 7.02 points at 6,674.74 - Focus turns to Apple and Facebook earnings - UK public sector net borrowing falls techMARK 2,742.15 +0.13% FTSE 100 6,674.74 -0.11% FTSE 250 15,989.64 -0.58% The FTSE 100 settled just slightly lower than its opening level as investors weighed corporate
Read moreFTSE 100 movers: ABF rises US expansion plans, broker upgrade
23rd Apr 2014 15:00
Associated British Foods was in the top spot on the FTSE 100 after the company announced its intention to expand its fast-growing Primark brand into the US towards the end of next year. Panmure Gordon upgraded its rating for the stock from 'hold' to 'buy'. saying: "This is sooner than we had antici
Read moreBroker tips: AB Foods, ARM, Wolseley...
23rd Apr 2014 12:59
Panmure Gordon has upgraded its rating for Associated British Foods from 'hold' to 'buy' after the company announced its intention to expand its fast-growing Primark brand into the US towards the end of next year. "This is sooner than we had anticipated, and whilst Primark will continue its measur
Read moreCiti upgrades AstraZeneca on under-appreciated pipeline
23rd Apr 2014 11:08
The potential value of AstraZeneca's (AZN) drug pipeline is still under-appreciated by the market, with or without a bid from US pharmaceutical peer Pfizer (PFE), according to Citigroup. The bank upgraded its rating for the stock from 'neutral' to 'buy' and hiked its target price for the shares fro
Read moreWednesday broker round-up UPDATE
23rd Apr 2014 09:04
AB Foods: Numis upgrades from sell to reduce with a target price of 2240p. AstraZeneca: Citi raises target price from 3500p to 4900p and upgrades to buy. Fenner: Investec cuts target price from 375p to 360p and reiterates its sell recommendation. Genus: N+1 Singer upgrades to hold with a target p
Read moreLondon open: Stocks edge higher, AB Foods jumps on Primark expansion
23rd Apr 2014 08:40
- AB Foods jumps on Primark expansion plans - Stocks rise, but upside limited - BoE minutes, economic data ahead - Chinese manufacturing PMI contracts again techMARK 2,749.64 +0.41% FTSE 100 6,688.65 +0.10% FTSE 250 16,067.20 -0.09% UK stocks edged higher on Wednesday morning with Primark owner As
Read moreWednesday tips round-up: Astra Zeneca, Torotrak
23rd Apr 2014 07:46
When a company says that it is willing to pay an over 30 per cent premium for one of its rivals, investors should sit up and take notice. Well, that's exactly what Pfizer did yesterday by offering to purchase AstraZeneca. Simply said, the British company's stock is cheap although the firm readily ad
Read moreLondon close: FTSE closes in positive territory, pharma stocks lead
22nd Apr 2014 16:15
- FTSE closes up 56.51 points at 6,681.76 - Easter weekend retail sales disappoint - Monthly US existing home sales down 0.4 per cent techMARK 2,738.48 +2.18% FTSE 100 6,681.76 +0.85% FTSE 250 16,082.24 +1.10% The FTSE 100 closed on an upbeat note today, having touched 6,700 earlier in the sessio
Read moreSector movers: M&A gives pharma stocks a big boost
22nd Apr 2014 15:28
Pharmaceuticals and biotechnology stocks were rising by an average of six per cent in London on Tuesday, helped by a wave of high-profile M&A deals across the global healthcare sector. Leading the charge in the UK was AstraZeneca on reports that it could be at the centre of the largest deal in phar
Read moreFTSE 100 movers: AstraZeneca surges on takeover speculation
22nd Apr 2014 14:37
AstraZeneca was rising strongly on speculation that Pfizer could make a takeover approach for the company, in a transaction valued in the region of 60bn pounds, representing the biggest deal ever in the industry's history and the largest foreign takeover of a UK business on record. While AstraZene
Read more